To investigate the effect of rare variation in a larger sample size of sporadic AD patients we have re-sequenced the coding regions of the Nicastrin gene in a cohort of AD patients and matched controls using an innovative pooling approach and next generation sequencing. The gene discussed is NCSTN; the disease is Alzheimer disease.